Posaconazole and Glipizide Interaction

Drug interaction information between Posaconazole and Glipizide.

Posaconazole and Glipizide have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Posaconazole and Glipizide. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Posaconazole

Azole Antifungal

Drug B

Glipizide

Sulfonylurea

How They Interact

Taking these two drugs together can interfere with how your body manages blood sugar, potentially causing your levels to drop too low.

FDA Label Information

7.14 Glipizide Although no dosage adjustment of glipizide is required, it is recommended to monitor glucose concentrations when posaconazole and glipizide are concomitantly used.

Frequently Asked Questions

What SPL severity band is on file for Posaconazole + Glipizide?

Compiled FDA labeling labels this pair minor. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Posaconazole has 27 labeled pairs on file vs Glipizide's 8. In the minor band specifically: Posaconazole has 17 (also Alprazolam, Diltiazem, Nifedipine, Verapamil); Glipizide has 8 (also Fluconazole, Colesevelam, Probenecid, Phenytoin).

What mechanism field is on file for Posaconazole and Glipizide?

Taking these two drugs together can interfere with how your body manages blood sugar, potentially causing your levels to drop too low.

Posaconazole carries more major-labeled pairs than Glipizide

SPL source-record counts only. This page's band is minor · classes on file: Posaconazole (Azole Antifungal); Glipizide (Sulfonylurea).

Posaconazole has 5 major-labeled pairs vs Glipizide's 0. This page itself is in the minor band, not the major band.

Posaconazole

5 major · 5 moderate · 17 minor · 27 total

Glipizide

0 major · 0 moderate · 8 minor · 8 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.